Literature DB >> 1316397

Cardiotoxicity and diuretics: much speculation--little substance.

G T McInnes, W W Yeo, L E Ramsay, M Moser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316397     DOI: 10.1097/00004872-199204000-00002

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  9 in total

Review 1.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 2.  Treatment of hypertension in children.

Authors:  A R Sinaiko
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 3.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

Review 4.  Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

Review 5.  Diuretics revisited--again.

Authors:  M Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738

6.  Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.

Authors:  Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

7.  Debate: does it matter how you lower blood pressure?

Authors:  Gordon T McInnes
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

8.  Preoperative evaluation of a patient for abdominal aortic aneurysm repair.

Authors:  A N Chonchubhair; A J Cunningham
Journal:  Yale J Biol Med       Date:  1998 Nov-Dec

9.  Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.